State of Alaska, Department of Revenue
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1370102
JUNEAU, AK
Position in SUPN
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$2,159,090
+$39,386 QoQ
Shares Held
41,770
-2.1% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026State of Alaska, Department of Revenue holds $37,937,359 across 27 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
20,052 | $11,890,434 | |
| 2 | ZTS |
Zoetis Inc.
|
42,100 | $4,976,641 | |
| 3 | ALKS |
Alkermes plc.
|
90,546 | $3,201,706 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
41,770 | $2,159,090 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
61,632 | $1,878,543 | |
| 6 | VTRS |
Viatris Inc
|
116,038 | $1,567,673 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
26,257 | $1,556,251 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
9,980 | $1,314,765 |
All Filings in SUPN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,159,090 | 41,770 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,119,704 | 42,650 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,489,135 | 31,160 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,050,056 | 33,314 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,002,051 | 30,597 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,134,809 | 31,383 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $980,798 | 31,456 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $864,372 | 32,313 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,135,249 | 33,282 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $972,702 | 33,611 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $937,131 | 33,991 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,077,470 | 35,844 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $1,341,162 | 37,018 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,342,690 | 37,642 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,254,819 | 37,070 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,168,396 | 40,401 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $1,195,710 | 36,996 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,098,048 | 37,656 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,034,022 | 38,771 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,129,808 | 36,694 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $937,872 | 35,824 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $1,031,660 | 41,004 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $1,026,828 | 49,272 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $1,177,097 | 49,562 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $837,470 | 46,552 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||